News | April 28, 2023
The news on a shift in its focus comes after the refinement of Bayer’s early innovation framework
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
Apollo continues to invest in genomics technology and research for better patient care
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution
The New State-of-Art OligoPilot 2000 solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs.
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
The interaction with key Government Officials and industry leaders led to a joint exploration of possible collaboration and investments in the Healthcare ecosystem between the two countries
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
Subscribe To Our Newsletter & Stay Updated
